EMA Authorised: Pedea (Ibuprofen) — Recordati Rare Diseases

View source ↗

Summary

The EMA authorised Pedea (ibuprofen) from Recordati Rare Diseases for use in patent ductus arteriosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Pedea (ibuprofen)

Snippet

Status: Authorised. Therapeutic area: Ductus Arteriosus, Patent. MAH: Recordati Rare Diseases. Decision date: 21/05/2025